ସର୍ଭିକାଲ୍ କ୍ୟାନ୍ସର
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ ଭାରତରେ ୩ଟି hospital ରୋଗୀଙ୍କୁ ନେଉଛି।
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
Cervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places women at high risk for CC is human immunodeficiency virus (HIV), as impaired immune response against Human papillomavirus (HPV) may result in persistent HR-HPV infection, a critical risk factor for progression of HPV-related cervical oncogenesis. Progression of precancerous lesions among women living with HIV (WLH) is…
ସ୍ପୋନ୍ସର: ୟୁନିଭର୍ସିଟି ଅଫ୍ କାଲିଫର୍ଣ୍ଣିଆ, ଇରଭିନ୍
ClinicalTrials.gov ରେ NCT07209917
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 31 ଜୁଲାଇ 2026 · ଆମେ ପଢ଼ିଲୁ 20 ଅକ୍ଟୋବର 2026